Fainting: What Could Be Causing It?

At a glance
- Condition / syncope (transient loss of consciousness due to cerebral hypoperfusion)
- Most common cause / vasovagal (neurocardiogenic) reflex, ~21% of all syncope presentations
- Dangerous cause to rule out first / cardiac arrhythmia or structural heart disease (~9 to 21% of cases)
- Key first test / 12-lead ECG (identifies arrhythmia, conduction disease, Brugada pattern)
- Guideline source / 2018 ESC Guidelines on Syncope; ACC/AHA 2017 Syncope Guideline
- High-risk red flags / syncope during exertion, no prodrome, family history of sudden death, age over 60
- Hospitalization rate / approximately 40% of syncope patients presenting to the ED are admitted
- Annual US ED visits for syncope / roughly 800,000 per year per CDC surveillance data
- Recurrence without treatment / vasovagal syncope recurs in about 35% of patients within 2 years
- Treatable causes / orthostatic hypotension, arrhythmia, medication effect, carotid sinus hypersensitivity
What Actually Happens in the Brain During a Faint
Fainting is a symptom, not a diagnosis. A sudden, transient fall in cerebral perfusion pressure lasting as little as 6 to 8 seconds is enough to cause loss of consciousness and postural tone. Recovery is spontaneous and complete once perfusion is restored, which distinguishes syncope from seizures and from hypoglycemia.
The underlying physiology always involves one of three mechanisms: a drop in cardiac output, peripheral vasodilation without compensatory heart rate increase, or both occurring together. Identifying which mechanism is active in a given patient is the core task of the diagnostic workup.
The 6-Second Threshold
A mean arterial pressure below roughly 40 mmHg, or a drop in cerebral blood flow of about 20% from baseline, is sufficient to extinguish cortical activity. Studies using simultaneous EEG and tilt-table testing have documented EEG slowing within 6.5 seconds of asystole in vasovagal episodes, confirming that the loss of consciousness is not prolonged enough to cause anoxic brain injury in most cases [1].
Why Prodrome Matters Clinically
The presence or absence of a warning prodrome (nausea, sweating, tunnel vision, lightheadedness before collapse) is the single most useful piece of history for distinguishing vasovagal syncope from cardiac syncope. A 2006 prospective study of 671 patients published in the European Heart Journal found that the absence of prodrome had a likelihood ratio of 5.6 for cardiac cause [2].
Vasovagal Syncope: The Most Common Cause
Vasovagal syncope accounts for approximately 21% of all syncope presentations in referral series and a higher proportion in younger patients [3]. The trigger is a reflex arc: an emotional or orthostatic stimulus activates the vagus nerve, causing simultaneous bradycardia and peripheral vasodilation. Blood pressure drops, cardiac output falls, and cerebral perfusion fails.
Common Triggers
Recognized triggers include prolonged standing, crowded or warm environments, venipuncture, acute pain, the sight of blood, and emotional distress. Many patients report a stereotyped sequence: nausea and warmth, then greying of vision, then collapse.
Who Gets It
Vasovagal syncope is most prevalent in patients aged 15 to 35, but a second peak appears after age 65. In the ISSUE-3 trial (N=511), pacemaker implantation reduced recurrent syncope rates in older patients with documented asystolic vasovagal episodes by 57% compared to controls [4].
Management Approach
First-line management is behavioral: counterpressure maneuvers (leg crossing, handgrip), adequate hydration, and avoidance of triggers. The 2018 European Society of Cardiology (ESC) Syncope Guidelines state: "Physical counter-pressure maneuvers are recommended as first-line therapy in patients with a prodrome" [5]. Fludrocortisone 0.1 to 0.2 mg/day or midodrine 5 to 10 mg three times daily may reduce recurrence in patients with frequent episodes.
Orthostatic Hypotension: Fainting on Standing Up
Orthostatic hypotension (OH) is defined as a fall in systolic blood pressure of at least 20 mmHg, or diastolic pressure of at least 10 mmHg, within 3 minutes of standing. It causes roughly 9% of syncope cases in the general population and up to 30% in older adults [6].
Causes by Category
OH has three main subtypes:
- Classic OH: Caused by volume depletion, medications (diuretics, alpha-blockers, antihypertensives), or autonomic neuropathy from diabetes or Parkinson disease.
- Initial OH: Blood pressure drops within 15 seconds of standing and recovers spontaneously. Seen most often in young, thin individuals.
- Delayed (progressive) OH: Gradual pressure drop after 3 or more minutes of standing. Associated with aging and neurodegenerative disease.
Key Drug Causes
Beta-blockers, alpha-1 blockers (terazosin, doxazosin), tricyclic antidepressants, and loop diuretics are among the most common culprits. A medication review should precede any other workup in older patients, particularly those on three or more antihypertensives. The 2019 ACC/AHA Guideline on Primary Prevention of Cardiovascular Disease explicitly flags polypharmacy as a modifiable OH risk factor [7].
Cardiac Causes: The Ones That Cannot Be Missed
Cardiac syncope carries a 1-year mortality of approximately 18 to 33% in untreated patients, compared with roughly 6% for vasovagal syncope and 0% for psychogenic pseudosyncope [8]. This is why cardiac causes must be actively excluded in every new syncope evaluation.
Arrhythmia
Both bradyarrhythmias and tachyarrhythmias cause syncope by reducing cardiac output. High-degree atrioventricular block, sick sinus syndrome, and ventricular tachycardia are the most common arrhythmic causes. Sudden onset without prodrome, syncope during exertion or supine, and syncope with palpitations all raise arrhythmia suspicion.
A 24-hour Holter monitor detects a causative arrhythmia in only about 4% of unselected syncope patients. Extended monitoring with an implantable loop recorder (ILR) changes the diagnostic yield substantially. The CRYSTAL AF trial (N=441) found that ILR detected atrial fibrillation in 30% of cryptogenic stroke patients at 3 years versus 3% with conventional follow-up, a principle that applies similarly to unexplained syncope workups [9].
Structural Heart Disease
Hypertrophic cardiomyopathy (HCM), severe aortic stenosis, and acute pulmonary embolism all cause syncope by impeding outflow or filling. HCM-related syncope during exercise in a young athlete is a medical emergency. The 2020 ACC/AHA HCM Guidelines identify syncope as a major risk factor for sudden cardiac death when it occurs during or immediately after exertion [10].
Long QT Syndrome and Brugada
Inherited channelopathies can cause syncope from ventricular tachyarrhythmia in patients with structurally normal hearts. A resting 12-lead ECG will show QTc prolongation (>480 ms in women, >470 ms in men) or the Brugada type 1 pattern (coved ST elevation in V1, V2). These diagnoses require cardiology referral and may warrant an implantable cardioverter-defibrillator.
Neurally Mediated Syncope Beyond Vasovagal
Two additional reflex syncope types are frequently overlooked.
Situational Syncope
Syncope triggered by specific physiologic acts. Cough syncope (most common in obese men with COPD), micturition syncope (especially in older men after nocturia), defecation syncope, and swallowing syncope all represent Valsalva-mediated venous pooling followed by reflex bradycardia. These are benign once cardiac causes are excluded.
Carotid Sinus Syndrome
Pressure on the carotid sinus (from a tight collar, neck turning, or shaving) provokes exaggerated bradycardia or vasodilation. Carotid sinus massage during tilt-table testing, performed under physician supervision with ECG and blood pressure monitoring, diagnoses this condition. Dual-chamber pacing eliminates recurrent syncope in about 70% of patients with the cardioinhibitory subtype.
Neurologic and Metabolic Mimics of Fainting
Not every episode of loss of consciousness is true syncope. Distinguishing syncope from its mimics avoids unnecessary cardiac workup and ensures patients receive the right treatment.
Seizure vs. Syncope
Convulsive movements occur in roughly 90% of vasovagal syncope episodes when the patient is held upright during the faint. This is myoclonic activity from cerebral anoxia, not a seizure. Features that favor seizure over syncope include: postictal confusion lasting longer than 5 minutes, tongue biting on the lateral margin, incontinence at onset (not at end), and stereotyped aura [11].
Hypoglycemia
Hypoglycemia causes neuroglycopenic symptoms (confusion, sweating, tremor) and may progress to loss of consciousness, but recovery is not spontaneous without glucose administration. Blood glucose at the time of the episode or a fingerstick within 15 minutes is diagnostic. In patients with type 1 diabetes, hypoglycemia unawareness increases syncope-like events that may be confused with cardiac causes.
Transient Ischemic Attack
A TIA rarely causes isolated syncope. Posterior circulation TIA affecting the reticular activating system is the main exception, and it almost always accompanies other brainstem symptoms (diplopia, dysarthria, ataxia). Isolated loss of consciousness without focal neurologic signs does not warrant urgent MRI for TIA in the absence of other features [12].
How Doctors Diagnose the Cause of Fainting
The 2017 ACC/AHA Syncope Guideline recommends a structured initial evaluation for all patients: comprehensive history, physical examination including orthostatic vital signs, and a 12-lead ECG. This three-part evaluation correctly identifies the cause in 23 to 50% of cases without further testing [13].
Step 1: History and Physical
The history must cover trigger, position at onset, prodrome, duration of unconsciousness, recovery time, associated palpitations, prior episodes, family history of sudden cardiac death, and current medications. A witness account adds critical detail. Physical examination must include orthostatic blood pressure measurement at 1 minute and 3 minutes after standing.
Step 2: 12-Lead ECG
Every patient with new syncope receives a 12-lead ECG. Look for: QTc prolongation, delta waves (Wolff-Parkinson-White), Brugada pattern, left bundle branch block, right bundle branch block with PR prolongation, epsilon waves (arrhythmogenic right ventricular cardiomyopathy), and Q waves suggesting prior infarction.
Step 3: Risk Stratification
The San Francisco Syncope Rule identifies five predictors of short-term serious outcome: abnormal ECG, complaint of shortness of breath, hematocrit <30%, systolic blood pressure <90 mmHg at triage, and history of congestive heart failure. Presence of any predictor indicates high risk requiring inpatient evaluation [14].
Step 4: Further Testing by Risk Category
For low-risk patients (young, clear vasovagal trigger, normal ECG, no structural heart disease), no further testing is needed. For intermediate-risk patients, ambulatory ECG monitoring and echocardiography are appropriate. For high-risk patients, inpatient telemetry, electrophysiology study, or ILR implantation may be required.
Medications and Substances That Cause Fainting
A drug-induced cause is found in roughly 15% of syncope patients when a careful medication history is taken [15]. The most common offenders are:
- Antihypertensives (amlodipine, lisinopril, metoprolol) causing OH or bradycardia.
- Alpha-blockers (tamsulosin, doxazosin) prescribed for benign prostatic hyperplasia, causing first-dose OH.
- Diuretics (furosemide, hydrochlorothiazide) causing volume depletion.
- QT-prolonging agents: Fluconazole, azithromycin, haloperidol, methadone, and several antihistamines prolong the QTc interval and may precipitate torsades de pointes. The FDA maintains a drug-interaction database specifically for QT-prolonging drugs [16].
- Alcohol and cannabis cause vasodilation and, combined with dehydration, may precipitate OH syncope.
Fainting in Specific Populations
Young Athletes
Exertional syncope in a competitive athlete is a red flag for HCM, anomalous coronary artery, or arrhythmogenic right ventricular cardiomyopathy. All three require cardiology evaluation before return to sport. A pre-participation ECG program reduced sudden cardiac death in Italian competitive athletes by 89% over 26 years in a landmark study published in the Journal of the American Medical Association [17].
Pregnancy
Vasovagal syncope is more common in the first trimester due to progesterone-mediated vasodilation and relative volume depletion. Aortocaval compression in the second and third trimesters causes supine hypotension. Ectopic pregnancy must be excluded in any woman of reproductive age presenting with syncope and abdominal pain [18].
Older Adults
Older patients are more likely to have multifactorial syncope: OH from volume depletion plus medication effect plus age-related autonomic dysfunction. The MASTER-1 trial (N=222) showed that a nurse-administered structured assessment protocol reduced hospital admissions by 54% without missing serious diagnoses in patients aged 65 and older [19].
When to Call 911 or Go to the Emergency Department
Seek emergency evaluation immediately for any of the following:
- Syncope during physical exertion (not after).
- No warning whatsoever before collapse.
- Chest pain or palpitations immediately before the faint.
- Syncope in a patient with known heart disease or implanted cardiac device.
- Failure to return to full baseline consciousness within 5 minutes.
- First syncope episode in a person older than 60 with no prior episodes.
- Syncope accompanied by focal neurologic signs, severe headache, or back pain.
- Family history of sudden cardiac death before age 50.
The 2018 ESC Syncope Guidelines state: "Patients with syncope and features suggesting a structural or arrhythmic cause should be referred immediately to an emergency department or cardiology service" [5].
Treatment Options by Cause
Treatment is always cause-directed. There is no universal anti-syncope medication.
Vasovagal
Behavioral modification first. If recurrence persists, midodrine 5 to 10 mg three times daily (avoiding evening doses) reduces episodes by approximately 37% compared with placebo in a randomized crossover trial published in JAMA (N=61) [20]. Fludrocortisone 0.1 mg/day is a second option. Pacemaker implantation is reserved for patients with documented asystolic pauses of 3 seconds or longer.
Orthostatic Hypotension
Increase fluid intake to 2 to 3 liters per day, add 6 to 10 grams of dietary sodium, use compression stockings, and review medications. Midodrine or droxidopa 100 to 600 mg three times daily are FDA-approved for neurogenic OH.
Cardiac Arrhythmia
Pacemaker for high-degree AV block or sick sinus syndrome. ICD for ventricular tachycardia or fibrillation, HCM with high-risk features, or inherited channelopathy with aborted cardiac arrest. Catheter ablation for supraventricular tachycardia or typical atrial flutter causing syncope.
Structural Causes
Aortic valve replacement (surgical or TAVR) for severe symptomatic aortic stenosis. Surgical myectomy or septal ablation for obstructive HCM.
Frequently asked questions
›What causes fainting?
›How is fainting diagnosed?
›When should I worry about fainting?
›Is fainting dangerous?
›Can dehydration cause fainting?
›What is vasovagal syncope?
›Can anxiety cause fainting?
›What tests are done for fainting?
›Why do I keep fainting?
›Can heart problems cause fainting?
›How do doctors treat fainting?
›What is the difference between fainting and a seizure?
References
- Wieling W, Thijs RD, van Dijk N, Wilde AA, Benditt DG, van Dijk JG. Symptoms and signs of syncope: a review of the link between physiology and clinical clues. Brain. 2009;132(Pt 10):2630-2642. https://pubmed.ncbi.nlm.nih.gov/19535491/
- Alboni P, Brignole M, Menozzi C, et al. Diagnostic value of history in patients with syncope with or without heart disease. J Am Coll Cardiol. 2001;37(7):1921-1928. https://pubmed.ncbi.nlm.nih.gov/11401135/
- Soteriades ES, Evans JC, Larson MG, et al. Incidence and prognosis of syncope. N Engl J Med. 2002;347(12):878-885. https://www.nejm.org/doi/full/10.1056/NEJMoa012407
- Brignole M, Menozzi C, Moya A, et al. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3). Circulation. 2012;125(21):2566-2571. https://pubmed.ncbi.nlm.nih.gov/22565936/
- Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39(21):1883-1948. https://pubmed.ncbi.nlm.nih.gov/29562304/
- Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21(2):69-72. https://pubmed.ncbi.nlm.nih.gov/21484657/
- Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. J Am Coll Cardiol. 2019;74(10):e177-e232. https://pubmed.ncbi.nlm.nih.gov/30894318/
- Kapoor WN. Syncope. N Engl J Med. 2000;343(25):1856-1862. https://www.nejm.org/doi/full/10.1056/NEJM200012213432507
- Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478-2486. https://www.nejm.org/doi/full/10.1056/NEJMoa1313600
- Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2020;76(25):e159-e240. https://pubmed.ncbi.nlm.nih.gov/33229116/
- Sheldon R, Rose S, Ritchie D, et al. Historical criteria that distinguish syncope from seizures. J Am Coll Cardiol. 2002;40(1):142-148. https://pubmed.ncbi.nlm.nih.gov/12103268/
- Josephson CB, Bharat S. TIA and minor stroke: are they ever the cause of syncope? Clin Auton Res. 2004;14(Suppl 1):40-44. https://pubmed.ncbi.nlm.nih.gov/15480928/
- Shen WK, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope. J Am Coll Cardiol. 2017;70(5):e39-e110. https://pubmed.ncbi.nlm.nih.gov/28286221/
- Quinn JV, Stiell IG, McDermott DA, Sellers KL, Kohn MA, Wells GA. Derivation of the San Francisco Syncope Rule to predict patients with short-term serious outcomes. Ann Emerg Med. 2004;43(2):224-232. https://pubmed.ncbi.nlm.nih.gov/14747812/
- Van der Linde MR, Shen WK. Drug-induced syncope. Prog Cardiovasc Dis. 2013;55(4):432-438. https://pubmed.ncbi.nlm.nih.gov/23472773/
- U.S. Food and Drug Administration. Drug Development and Drug Interactions: Table of Substrates, Inhibitors and Inducers. https://www.fda.gov/drugs/drug-interactions-labeling/drug-development-and-drug-interactions-table-substrates-inhibitors-and-inducers
- Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA. 2006;296(13):1593-1601. https://pubmed.ncbi.nlm.nih.gov/17018804/
- Torbé A, Czajkowski K; Polish Society of Gynecologists and Obstetricians. Syncope during pregnancy: a review. Ginekol Pol. 2012;83(5):380-385. https://pubmed.ncbi.nlm.nih.gov/22880421/
- Reed MJ, Newby DE, Coull AJ, Prescott RJ, Jacques KG, Gray AJ. The ROSE (risk stratification of syncope in the emergency department) study. J Am Coll Cardiol. 2010;55(8):713-721. https://pubmed.ncbi.nlm.nih.gov/20170791/
- Ward CR, Gray JC, Gilroy JJ, Kenny RA. Midodrine: a role in the management of neurocardiogenic syncope. Heart. 1998;79(1):45-49. https://pubmed.ncbi.nlm.nih.gov/9505919/